Torque Unveils Manufacturing Platform for Its "Deep Primed" T-Cell Cancer Therapies

Torque, a developer of T-cell cancer therapeutics produced through its Deep-Priming™ technology platform said today it has created a manufacturing process that will produce its T-cell cancer therapies and deliver them to patients much more quickly and inexpensively than current methods.The company announced that its Slipstream™ process for making Deep-Primed T-Cells is in place at the GMP facility of University of California, Davis, which has collaborated wit